- Home
- NTRP vs NEUP Comparison
NTRP vs NEUP Comparison
Compare NTRP & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- NEUP
- Stock Information
- Founded
- NTRP 1985
- NEUP 1996
- Country
- NTRP United States
- NEUP United States
- Employees
- NTRP N/A
- NEUP N/A
- Industry
- NTRP
- NEUP
- Sector
- NTRP
- NEUP
- Exchange
- NTRP NYSE
- NEUP Nasdaq
- Market Cap
- NTRP 12.7M
- NEUP 12.7M
- IPO Year
- NTRP N/A
- NEUP N/A
- Fundamental
- Price
- NTRP $3.55
- NEUP $7.13
- Analyst Decision
- NTRP Hold
- NEUP Strong Buy
- Analyst Count
- NTRP 1
- NEUP 1
- Target Price
- NTRP $5.00
- NEUP $21.00
- AVG Volume (30 Days)
- NTRP 50.0K
- NEUP 26.7K
- Earning Date
- NTRP 05-29-2025
- NEUP 08-15-2025
- Dividend Yield
- NTRP N/A
- NEUP N/A
- EPS Growth
- NTRP N/A
- NEUP N/A
- EPS
- NTRP N/A
- NEUP 0.00
- Revenue
- NTRP $501,422.00
- NEUP $15,662,715.00
- Revenue This Year
- NTRP $2,544.87
- NEUP N/A
- Revenue Next Year
- NTRP N/A
- NEUP N/A
- P/E Ratio
- NTRP N/A
- NEUP $2.30
- Revenue Growth
- NTRP 9.30
- NEUP N/A
- 52 Week Low
- NTRP $1.39
- NEUP $2.90
- 52 Week High
- NTRP $8.50
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- NTRP 58.20
- NEUP N/A
- Support Level
- NTRP $3.24
- NEUP N/A
- Resistance Level
- NTRP $3.98
- NEUP N/A
- Average True Range (ATR)
- NTRP 0.44
- NEUP 0.00
- MACD
- NTRP 0.02
- NEUP 0.00
- Stochastic Oscillator
- NTRP 45.83
- NEUP 0.00
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.